Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Elimination of oncogenic KRAS in genetic mouse models eradicates pancreatic cancer by inducing FAS-dependent apoptosis by CD8+ T cells
Krishnan K. Mahadevan, Valerie S. LeBleu, Elena V. Ramirez, et al.
Developmental Cell (2023) Vol. 58, Iss. 17, pp. 1562-1577.e8
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

Exploiting the therapeutic implications of KRAS inhibition on tumor immunity
Míriam Molina‐Arcas, Julian Downward
Cancer Cell (2024) Vol. 42, Iss. 3, pp. 338-357
Open Access | Times Cited: 46
Cold and hot tumors: from molecular mechanisms to targeted therapy
Bo Wu, Bo Zhang, Bowen Li, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 34
Current and future immunotherapeutic approaches in pancreatic cancer treatment
Pooya Farhangnia, Hossein Khorramdelazad, Hamid Nickho, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 29
Recent advances in drug delivery and targeting for the treatment of pancreatic cancer
Nilkamal Pramanik, Aditya K. Gupta, Yashwardhan Ghanwatkar, et al.
Journal of Controlled Release (2024) Vol. 366, pp. 231-260
Closed Access | Times Cited: 13
Pancreatic cancer biomarkers: A pathway to advance in personalized treatment selection
Elena Brozos-Vázquez, Marta Toledano‐Fonseca, Nicolás Costa‐Fraga, et al.
Cancer Treatment Reviews (2024) Vol. 125, pp. 102719-102719
Open Access | Times Cited: 6
Investigating underlying molecular mechanisms, signaling pathways, emerging therapeutic approaches in pancreatic cancer
Mohd Rais Mustafa, Kashif Abbas, Mudassir Alam, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 6
Convergent inducers and effectors of T cell paralysis in the tumour microenvironment
Douglas Hanahan, Olivier Michielin, Mikaël J. Pittet
Nature reviews. Cancer (2024)
Closed Access | Times Cited: 6
Evaluation of KRAS inhibitor-directed therapies for pancreatic cancer treatment
Szu-Aun Long, Amber M. Amparo, Grace Goodhart, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 5
Personalized Medicine in Pancreatic Cancer: The Promise of Biomarkers and Molecular Targeting with Dr. Michael J. Pishvaian
Viviana Cortiana, Rabab Hunaid Abbas, Harshal Chorya, et al.
Cancers (2024) Vol. 16, Iss. 13, pp. 2329-2329
Open Access | Times Cited: 5
Advances in Novel Targeted Therapies for Pancreatic Adenocarcinoma
Tuan Hoang, Erica S. Tsang
Journal of Gastrointestinal Cancer (2025) Vol. 56, Iss. 1
Closed Access
The Landmark Series: The Future of Pancreatic Cancer Clinical Trials
Yongwoo David Seo, Matthew H. G. Katz, Rebecca A. Snyder
Annals of Surgical Oncology (2025) Vol. 32, Iss. 4, pp. 2777-2785
Closed Access
Distinct molecular and clinical features of specific variants of KRAS codon 12 in pancreatic adenocarcinoma
Bach Ardalan, Aaron Ciner, Yasmine Baca, et al.
Clinical Cancer Research (2025)
Open Access
KRASG12D-driven pentose phosphate pathway remodeling imparts a targetable vulnerability synergizing with MRTX1133 for durable remissions in PDAC
Xiangyan Jiang, Tao Wang, Bin Zhao, et al.
Cell Reports Medicine (2025) Vol. 6, Iss. 2, pp. 101966-101966
Open Access
Adoptive cell therapy against tumor immune evasion: mechanisms, innovations, and future directions
Liqin Ruan, Lu Wang
Frontiers in Oncology (2025) Vol. 15
Open Access
Acetylated Dendrobium huoshanense polysaccharide: a novel inducer of apoptosis in colon cancer cells via Fas–FasL pathway activation and metabolic reprogramming
Liang Yao, Chen Gu, Ruipeng Ge, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
KRASG12D-Specific Targeting with Engineered Exosomes Reprograms the Immune Microenvironment to Enable Efficacy of Immune Checkpoint Therapy in PDAC Patients
Valerie S. LeBleu, Brandon G. Smaglo, Krishnan K. Mahadevan, et al.
medRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Inhibitors of oncogenic Kras specifically prime CTLA4 blockade to transcriptionally reprogram Tregs and overcome resistance to suppress pancreas cancer
Krishnan K. Mahadevan, Antonio Maldonado, Bingrui Li, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
Immune-Based Strategies for Pancreatic Cancer in the Adjuvant Setting
Kaili Liang, Nilofer S. Azad
Cancers (2025) Vol. 17, Iss. 7, pp. 1246-1246
Open Access
Inhibition of GTPase KRAS G12D : a review of patent literature
Yuhang Li, Le Yang, Xiaoran Li, et al.
Expert Opinion on Therapeutic Patents (2024) Vol. 34, Iss. 8, pp. 701-721
Closed Access | Times Cited: 4
The PRC2 complex epigenetically silences GATA4 to suppress cellular senescence and promote the progression of breast cancer
Wenqian Yu, Xiaona Lin, Shuai Leng, et al.
Translational Oncology (2024) Vol. 46, pp. 102014-102014
Open Access | Times Cited: 2
Drugging the undruggable: Advances in targeting KRAS signaling in solid tumors
Prajna Tripathi, Rajni Kumari, Rajiv Pathak
International review of cell and molecular biology (2024), pp. 1-39
Closed Access | Times Cited: 1
Combination of mutations in genes controlling DNA repair and high mutational load plays a prognostic role in pancreatic ductal adenocarcinoma (PDAC): a retrospective real-life study in Sardinian population
Maria Cristina Sini, Maria Grazia Doro, Laura Frogheri, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
KRASG12D inhibition in pancreatic cancer: Fas expression facilitates immune clearance
Celine Yeh, Wungki Park, Rona Yaeger
Developmental Cell (2023) Vol. 58, Iss. 17, pp. 1515-1516
Open Access | Times Cited: 2
Combination of mutations in genes controlling DNA repair and high mutational load plays a prognostic role in pancreatic ductal adenocarcinoma (PDAC): a retrospective real-life study in Sardinian population
Maria Cristina Sini, MariaGrazia Doro, Laura Frogheri, et al.
Research Square (Research Square) (2024)
Open Access
PCIF1 is partly cytoplasmic, dynamically localizes to stress granules and binds mRNA coding regions upon oxidative stress
Trinh Tat, Sabeen Raza, Shaheerah Khan, et al.
(2024)
Open Access
Page 1 - Next Page

Scroll to top